Crinetics Pharmaceuticals, Inc. Payments to Acquire Debt Securities, Available-for-sale
Crinetics Pharmaceuticals, Inc. (CRNX) reported Payments to Acquire Debt Securities, Available-for-sale of $709.64 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt · last filed 2026-08-03
- Crinetics Pharmaceuticals, Inc. payments to acquire debt securities, available-for-sale for the quarter ending 2026-06-30 was $155.21M, a 15.13% decline year-over-year.
- Crinetics Pharmaceuticals, Inc. payments to acquire debt securities, available-for-sale for the quarter ending 2026-03-31 was $554.43M, a 41.72% increase year-over-year.
- Crinetics Pharmaceuticals, Inc. payments to acquire debt securities, available-for-sale for the quarter ending 2025-12-31 was $213.65M, a 70.53% decline year-over-year.
- Crinetics Pharmaceuticals, Inc. payments to acquire debt securities, available-for-sale for the quarter ending 2025-09-30 was $216.70M, a 66.67% increase year-over-year.
- Crinetics Pharmaceuticals, Inc. payments to acquire debt securities, available-for-sale for fiscal 2025 was $1.00B, a 12.41% decline from fiscal 2024.
- Crinetics Pharmaceuticals, Inc. payments to acquire debt securities, available-for-sale for fiscal 2024 was $1.15B, a 117.25% increase from fiscal 2023.
- Crinetics Pharmaceuticals, Inc. payments to acquire debt securities, available-for-sale for fiscal 2023 was $527.86M, a 60.05% increase from fiscal 2022.
- Crinetics Pharmaceuticals, Inc. payments to acquire debt securities, available-for-sale for fiscal 2022 was $329.82M, a 163.00% increase from fiscal 2021.
| Period end | Payments to Acquire Debt Securities, Available-for-sale 3 month | Payments to Acquire Debt Securities, Available-for-sale 6 month | Payments to Acquire Debt Securities, Available-for-sale 9 month | Payments to Acquire Debt Securities, Available-for-sale 12 month |
|---|---|---|---|---|
| 2026-06-30 | $155.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $709.64M 10-Q · filed 2026-08-03 | $923.28M derived: sum of 3 quarters · filed 2026-08-03 | $1.14B derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | $554.43M 10-Q · filed 2026-05-07 | $768.07M derived: sum of 2 quarters · filed 2026-05-07 | $984.77M derived: sum of 3 quarters · filed 2026-05-07 | $1.17B derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | $213.65M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $430.35M derived: sum of 2 quarters · filed 2026-02-26 | $613.22M derived: sum of 3 quarters · filed 2026-08-03 | $1.00B 10-K · filed 2026-02-26 |
| 2025-09-30 | $216.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $399.58M derived: sum of 2 quarters · filed 2026-08-03 | $790.78M 10-Q · filed 2025-11-06 | $1.52B derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $182.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $574.08M 10-Q · filed 2026-08-03 | $1.30B derived: sum of 3 quarters · filed 2026-08-03 | $1.43B derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | $391.20M 10-Q · filed 2026-05-07 | $1.12B derived: sum of 2 quarters · filed 2026-05-07 | $1.25B derived: sum of 3 quarters · filed 2026-05-07 | $1.44B derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $725.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $855.04M derived: sum of 2 quarters · filed 2026-02-26 | $1.05B derived: sum of 3 quarters · filed 2026-02-26 | $1.15B 10-K · filed 2026-02-26 |
| 2024-09-30 | $130.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $322.00M derived: sum of 2 quarters · filed 2025-11-06 | $421.74M 10-Q · filed 2025-11-06 | $594.79M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $191.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $291.73M 10-Q · filed 2025-08-07 | $464.78M derived: sum of 3 quarters · filed 2026-02-26 | $737.42M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $99.74M 10-Q · filed 2025-05-08 | $272.79M derived: sum of 2 quarters · filed 2026-02-26 | $545.43M derived: sum of 3 quarters · filed 2026-02-26 | $604.93M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $173.05M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $445.69M derived: sum of 2 quarters · filed 2026-02-26 | $505.19M derived: sum of 3 quarters · filed 2026-02-26 | $527.86M 10-K · filed 2026-02-26 |
| 2023-09-30 | $272.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $332.13M derived: sum of 2 quarters · filed 2024-11-12 | $354.81M 10-Q · filed 2024-11-12 | $388.37M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $59.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $82.17M 10-Q · filed 2024-08-08 | $115.73M derived: sum of 3 quarters · filed 2025-02-27 | $164.41M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $22.67M 10-Q · filed 2024-05-09 | $56.23M derived: sum of 2 quarters · filed 2025-02-27 | $104.92M derived: sum of 3 quarters · filed 2025-02-27 | $297.47M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $33.56M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $82.25M derived: sum of 2 quarters · filed 2025-02-27 | $274.80M derived: sum of 3 quarters · filed 2025-02-27 | $329.82M 10-K · filed 2025-02-27 |
| 2022-09-30 | $48.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $241.24M derived: sum of 2 quarters · filed 2023-11-07 | $296.26M 10-Q · filed 2023-11-07 | $398.28M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $192.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $247.57M 10-Q · filed 2023-08-08 | $349.60M derived: sum of 3 quarters · filed 2024-02-28 | $370.44M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $55.02M 10-Q · filed 2023-05-09 | $157.04M derived: sum of 2 quarters · filed 2024-02-28 | $177.89M derived: sum of 3 quarters · filed 2024-02-28 | $177.89M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $102.02M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $122.87M derived: sum of 2 quarters · filed 2024-02-28 | $122.87M derived: sum of 3 quarters · filed 2024-02-28 | $125.40M 10-K · filed 2024-02-28 |
| 2021-09-30 | $20.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $20.84M derived: sum of 2 quarters · filed 2022-11-14 | $23.38M 10-Q · filed 2022-11-14 | $45.21M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $2.54M 10-Q · filed 2022-08-12 | $24.36M derived: sum of 3 quarters · filed 2023-02-28 | $68.03M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $2.54M 10-Q · filed 2022-05-12 | $24.36M derived: sum of 2 quarters · filed 2023-02-28 | $68.03M derived: sum of 3 quarters · filed 2023-02-28 | $115.24M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $21.83M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $65.49M derived: sum of 2 quarters · filed 2023-02-28 | $112.71M derived: sum of 3 quarters · filed 2023-02-28 | $135.59M 10-K · filed 2023-02-28 |
| 2020-09-30 | $43.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $90.88M derived: sum of 2 quarters · filed 2021-11-05 | $113.76M 10-Q · filed 2021-11-05 | $154.83M derived: sum of 4 quarters · filed 2022-03-30 |
| 2020-06-30 | $47.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $70.10M 10-Q · filed 2021-08-10 | $111.17M derived: sum of 3 quarters · filed 2022-03-30 | $125.57M derived: sum of 4 quarters · filed 2022-03-30 |
| 2020-03-31 | $22.89M 10-Q · filed 2021-05-06 | $63.95M derived: sum of 2 quarters · filed 2022-03-30 | $78.36M derived: sum of 3 quarters · filed 2022-03-30 | $99.46M derived: sum of 4 quarters · filed 2022-03-30 |
| 2019-12-31 | $41.07M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $55.47M derived: sum of 2 quarters · filed 2022-03-30 | $76.57M derived: sum of 3 quarters · filed 2022-03-30 | $108.14M 10-K · filed 2022-03-30 |
| 2019-09-30 | $14.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $35.51M derived: sum of 2 quarters · filed 2020-11-06 | $67.07M 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $21.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $52.66M 10-Q · filed 2020-08-07 | ||
| 2019-03-31 | $31.56M 10-Q · filed 2020-05-08 | |||
| 2018-12-31 | $118.40M 10-K · filed 2021-03-30 |